OR WAIT null SECS
ClearTrial announced the release of v3.0 of its web-based clinical trial software. ClearTrial v3.0 introduces ClearTrial TRACK enabling fast and accurate project tracking, management of accrued liabilities, and reforecasting for change orders and midstream study adjustments. ClearTrial v3.0 seamlessly combines ClearTrial PLAN, ClearTrial SOURCE software and ClearTrial TRACK, providing an integrated management platform for clinical trial planning, forecasting, outsourcing, and project and financial tracking.
ClearTrial v3.0 eliminates one of the barriers to operational efficiency in clinical operations: the lack of a fast, accurate, and consistent framework for managing clinical trial information. With v3.0 and ClearTrial TRACK, life sciences companies can quickly create clinical trial cost, resource, and timeline forecasts; efficiently negotiate and manage outsourced studies and licensing arrangements; and easily track projects against a detailed operational plan to pinpoint cost variances, underperforming studies, and accrued liabilities.
“Given the intense pressures today on pharmaceutical and biotechnology companies to support growing levels of global clinical research activity under tighter budgets, aggressive time lines and heavy capacity constraints," said Ken Getz, senior research fellow at Tufts Center for the Study of Drug Development, "there is a huge premium that sponsor companies -- and their contract service providers -- are placing on more effective resource planning and management solutions."
ClearTrial TRACK provides a “dashboard” view of studies, with early warnings to budget overruns and underperforming projects, as well as Earned Value Management (EVM) metrics tailored for use in clinical development. The software allows users to compare planned against actual progress; quickly obtain schedule and cost performance as well as percent complete; and get detailed analyses of project trends, including time to project completion and its estimated cost at completion.
In addition, ClearTrial v3.0 further enhances the software's ability to help life sciences companies plan and manage global clinical trials, with the addition of expanded currency support and the setting of exchange rates. Combined with country-specific industry intelligence such as regulatory delays, patient enrollment rates, and monitoring costs, the enhanced ability to plan and track projects in the currency of choice provides unmatched capabilities for conducting single-country, regional, or global studies.